Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Thompson Juliet, Director. Insider active across 2 companies, notably Indivior Pharmaceuticals, Inc.. In total, 2 disclosures have been recorded. History available since 26 January 2026. The latest transaction was filed on 12 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Juliet Thompson is a Director at Indivior Pharmaceuticals, Inc. She contributes to the governance of the company and strategic decision-making. Her experience in the pharmaceutical sector is an asset to the board of directors. She plays a key role in the future direction of Indivior.